Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketoreductase Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119823958A details a ketoreductase mutant for synthesizing chiral intermediates. This report analyzes supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110257351A reveals high-activity enzyme mutants for chiral alcohol synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN116179502A details a novel ketoreductase mutant enabling >99% ee chiral alcohol synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN115537405A reveals a novel ketoreductase mutant for high-purity (S)-1-(3-chlorophenyl)-1,3-propanediol production, offering significant cost reduction in API manufacturing.
Patent CN114807246A details high-efficiency enzymatic reduction for chiral alcohols, offering superior stereoselectivity and industrial scalability for pharmaceutical intermediates.
Patent CN111662889B discloses a novel ketoreductase mutant enabling efficient synthesis of Darunavir intermediates with high substrate loading and reduced costs.